Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This editorial review sits within the PlexusDx Education Hub, our evidence-based resource on GLP-1 therapies, weight protocols, and the genetics behind metabolic care. Browse all Peptides & GLP-1 education
This is an independent editorial review. PlexusDx holds no commercial relationship with Brello or its parent company, and there are no affiliate links or compensation behind it.
Brello is one of many telehealth entrants in the GLP-1 and weight management market, and cost is the question readers ask first. This review breaks down how the program is structured to price, what tends to be bundled, and what drives the total, in fair-balance terms rather than as a buying recommendation, as of April 2026.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
The company, in brief
Brello (Brello Health) operates as a telehealth plus compounded pharmacy model. Programs of this kind generally include a virtual clinical evaluation by a licensed provider, a written prescription routed either to a retail pharmacy for FDA-approved brand products or to a 503A compounding pharmacy for compounded semaglutide or tirzepatide, and ongoing follow-up. Consult Brello's official website (search for the current URL at the time of reading) for its live program structure and pricing.
How the program is structured to price
Most telehealth GLP-1 programs follow the same sequence: an intake form capturing weight, medical history, and current medications; clinician review and, if eligibility is met, a prescription; routing to a retail or licensed compounding pharmacy; then ongoing telehealth follow-up for titration and side effects. Cost attaches at several of those steps, which is why a single headline number rarely tells the whole story.
What actually drives your total spend
Published pricing lives on Brello's own site, and the total moves with product choice (semaglutide versus tirzepatide versus other), subscription tier, and whether the brand dispenses FDA-approved brand products or compounded alternatives. Across the telehealth GLP-1 market as of April 2026, typical monthly totals land somewhere between roughly $200 and $700 or more, with wide variance. Because these numbers change frequently, verify current pricing at Brello's official website (search for the current URL at the time of reading) before committing.
The pharmacology your money is buying
Whatever the price tier, the biology is driven by the compound class: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide). Anchor trials include STEP (semaglutide for weight management, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Trial populations and endpoints differ, and outcomes vary individually.
The line item no program prices: your genetics
No telehealth program in this model prices in the upstream genetic architecture that shapes every GLP-1 response. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene, the target of every GLP-1 compound), MC4R (a melanocortin receptor central to satiety and energy balance), and TCF7L2 (a transcription factor linked to glucose homeostasis and GLP-1 secretion) map the metabolic terrain any compound acts on. These variants are pathway-level; they do not predict response to any specific compound, but they describe the biology a clinician is prescribing into, which a telehealth checkout does not capture.
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. The difference is what comes before the checkout: the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R, and TCF7L2 variants that shape your baseline GLP-1, appetite, and energy-balance biology, so spend is guided by your own metabolic profile.
Not affiliated: PlexusDx is not affiliated with Brello and has no commercial relationship with the companies reviewed in this article.
Related reading on PlexusDx: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs.
Disclaimer: This article is educational. PlexusDx is not affiliated with Brello and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Compare the PlexusDx approach: see the Weight Management Protocols, semaglutide and tirzepatide with the genetic context most telehealth programs skip. Or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.
Frequently Asked Questions
How is Brello priced?
Brello publishes pricing on its own website, and the total varies with the product, the subscription tier, and whether fulfillment is a brand product or a compounded alternative. Telehealth GLP-1 programs generally span roughly $200 to $700 or more per month as of April 2026. Verify current numbers on the brand's site before committing.
What is bundled into the monthly cost?
Programs in this model typically bundle clinical evaluation, the prescription, pharmacy fulfillment, and follow-up, with the medication itself sometimes billed separately. Because cost attaches at several steps, a single advertised figure may not reflect total spend. Read the terms carefully and confirm what the headline price does and does not include.
Is cash-pay compounded telehealth cheaper than brand?
It can be, since compounded semaglutide or tirzepatide from a licensed 503A pharmacy is often priced below branded list price. Trade-offs include regulatory complexity and variation in oversight. Coverage rarely applies to cash-pay compounded telehealth, so compare total out-of-pocket spend, not just a per-month sticker.
How does the genetic test relate to cost?
The Precision Peptide Genetic Test does not predict response to any program or compound. It analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that shape baseline GLP-1 biology, upstream context that applies no matter which telehealth service prescribes, helping direct spend toward an informed provider conversation.
This review is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Bioverse Weight Loss: Program Model, Eligibility, and Pricing
Brello Pricing: Why Retail Coupons Don't Apply Here